“…We used atenolol (Bogaert, Rosseel, & Lefebvre, 1984;Prachi, Komal, & Priti, 2017), ICI 118,551 (Baker, 2010;Propping, Newe, Kaumann, Wirth, & Ravens, 2015) and propranolol (Hoffmann, Leitz, Oberdorf-Maass, Lohse, & Klotz, 2004;Tan & Yang, 2016;Zhang et al, 2011b) as the selective β 1 -AR, selective β 2 -AR and non-selective β-AR antagonists, respectively. The doses of the β-AR antagonists were selected according to our previous experimental data, which were shown to be the optimal doses for stable monitoring of haemodynamics (Zhang et al, 2011a(Zhang et al, , 2012.…”